Molnupiravir N-1 CAS 2346620-55-9 COVID-19 High Quality
Commercial Supple Molnupiravir and Related media with High Quality
Uridine CAS 58-96-8
Cytidine CAS 65-46-3
Molnupiravir N-1 CAS 2346620-55-9
Molnupiravir (EIDD-2801) CAS 2349386-89-4
| Nomen chemicum | Molnupiravir N-1 |
| Synonyma | ((3aR,4R,6R,6aR)-6-((E)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)-2,2-dimethyltetrahydrofuro[3; 4-d][1,3]dioxol-4-yl)methyl isobutyrate;Molnupiravir Medium;Molnupiravir Dimethyl Dioxol Impuritas;Molnupiravir immunditia 11 |
| CAS Number | 2346620-55-9 |
| CATTUS Number | RF-PI310 |
| Stock Status | In Stock, Productio Ascendite usque ad Centum chiliogrammata |
| Formulae hypotheticae | C16H23N3O7 |
| M. Pondus | 369.37 |
| Solubilitas | Solutum in DMSO |
| Density | 1.51±0.1 g/cm3 |
| Shipping Temperature | Ambiens |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Aspectus | Alba ad Off-White pulveris |
| Damnum in Siccatio | ≤1.0% |
| Residere in Ignition | ≤0.20% |
| una immunditia | ≤0.50% |
| Totalis immunditias | ≤2.0% |
| Metalla gravis | ≤20ppm |
| Puritas | ≥98.0% |
| Test Standard | Enterprise Standard |
| Consuetudinem | Medium Molnupiravir (CAS 2349386-89-4) COVID-19 |
sarcina: Utrem, aluminium foil, pera, cardboard tympanum, 25kg/Drum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.
Molnupiravir N-1 (CAS 2346620-55-9), est medius Molnupiravir (CAS 2349386-89-4) in tractatu de COVID-19.Molnupiravir (EIDD-2801) forma bioavailable oretenus est analog ribonucleoside valde potente, quae replicationem plurium RNA virus inclusorum SARS-CoV-2 vetat, agentis causativum COVID-19.EIDD-2801 (7 mg/kg; po; bis cotidie per 3.5 dies) significanter virus effundit et durationem febrium minuit.Molnupiravir (EIDD-2801) efficaciter hydrolyzatus est in vivo post absorptionem, inde in detectione solum liberorum NHC in plasmate.EIDD-2801 robuste reducet MERS-CoV titeros infectiosas, RNA virales et pathogenesis sub condiciones tum prophylacticae et primae therapeuticae.Molnupiravir (EIDD-2801, MK-4482) est viva monstruosum prodrug ribonucleosidum analogi β-d-N4-hydroxycytidinis (NHC; EIDD-1931) cum lato-spectro antivirali contra SARS-CoV-2, MERS-CoV, SARS-CoV ac causativum COVID-19.
